CSIMarket Company Name, Ticker, Competitors, else..
 
Xbiotech Inc   (NASDAQ: XBIT)
 
Price: $2.2000 $0.00 0.000%
Day's High: $2.2200000286102295 Week Perf: -4.35 %
Day's Low: $ 2.19 30 Day Perf: -3.51 %
Volume (M): 113,552 52 Wk High: $ 3.44
Volume (M$): $ 0 52 Wk Avg: $2.43
Open: $2.20 52 Wk Low: $2.09



 Market Capitalization (Millions $) 67
 Shares Outstanding (Millions) 30
 Employees 85
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -45
 Cash Flow (TTM) (Millions $) -37
 Capital Exp. (TTM) (Millions $) 0

Business Description


Xbiotech Inc is a biopharmaceutical company based in Austin, Texas. The company focuses on the discovery, development, and commercialization of antibody therapies for various diseases. Xbiotech's main therapeutic approach involves harnessing the power of the immune system to fight diseases including cancer, infectious diseases, and inflammatory conditions. The company has an established pipeline of monoclonal antibody candidates and has received approval for some of its products in Europe. Xbiotech Inc is committed to advancing innovative treatments and improving patient outcomes.


   Company Address: 5217 Winnebago Ln Austin 78744 TX
   Company Phone Number: 386-2900   Stock Exchange / Ticker: NASDAQ XBIT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
JNJ        2.68% 
MRK        1.33% 
PFE        1.75% 
TEVA   -0.22%    
VRTX        0.82% 
VTRS        3.3% 
• View Complete Report
   



Clinical Study

Healthcare Workforce Management Market Hits $1.7B in 2024, Surging to $2.8B by 2029 with a 10.1% CAGR | MarketsandMar...

Published Wed, Jun 19 2024 12:30 PM UTC

Revolutionizing Healthcare Workforce Management: Market to Reach $2.8B by 2029 The healthcare workforce management systems market has shown remarkable growth over recent years, with projections indicating substantial future expansion. In 2024, the market valuation reached $1.7 billion and is anticipated to soar to $2.8 billion by 2029. This growth translates to a significan...
Clinical Study

XBiotechs Innovative Combination Therapy Shows Potential Breakthrough in Advanced Pancreatic Cancer Treatment ...

Published Tue, Jun 18 2024 3:35 PM UTC

Potential Breakthrough in Pancreatic Cancer Treatment Emerges from XBiotech s Phase 1/2 StudyPancreatic cancer remains one of the most formidable oncological challenges, characterized by late-stage diagnosis and poor prognosis. However, a recent randomized double-blinded Phase 1/2 study conducted by XBiotech has yielded results that hint at a promising advancement in treati...
Product Service News

XBiotech Unveils Ambitious Plans for State-of-the-Art R&D Facility, Bolstering Innovation in Biotechnology

Published Thu, Jan 4 2024 2:03 PM UTC

XBiotech Inc., a leading biotechnology company based in Austin, Texas, has set its sights on significant growth with the announcement of plans to construct a state-of-the-art research and development facility. The company has received approval from the City of Austin and is set to commence excavation and site preparation for this groundbreaking project in the first quarter o...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 0.52
PEG (TTM) -

Financial Strength Current
Quick Ratio 32.67
Working Capital Ratio 33.15
Leverage Ratio (MRQ) 0.04
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.48 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 3.59 $
Book Value 4.21 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -530,976
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.